Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 81, 240-50

Cardiotoxicity Screening With Simultaneous Optogenetic Pacing, Voltage Imaging and Calcium Imaging

Affiliations

Cardiotoxicity Screening With Simultaneous Optogenetic Pacing, Voltage Imaging and Calcium Imaging

Graham T Dempsey et al. J Pharmacol Toxicol Methods.

Abstract

Introduction: The Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative seeks an in vitro test to accurately predict clinical Torsades de Pointes (TdP). We developed a cardiotoxicity assay incorporating simultaneous measurement of the action potential (AP) waveform and Ca(2+) transient (CT) in human iPSC-derived cardiomyocytes (CMs). Concurrent optogenetic pacing provided a well-controlled electrophysiological background.

Methods: We used the Optopatch platform for all-optical electrophysiology (Hochbaum et al., 2014). In a monolayer culture, a subset of cells expressed a genetically encoded, calcium and voltage reporter, CaViar (Hou, Kralj, Douglass, Engert, & Cohen, 2014), while others expressed a channelrhodopsin variant, CheRiff. Optical pacing of CheRiff-expressing cells synchronized the syncytium. We screened 12 compounds (11 acute, 1 chronic) to identify electrophysiological (AP rise time, AP50, AP90, beat rate) and CT effects in spontaneously beating and paced cultures (1Hz, 2Hz).

Results: CaViar reported spontaneous and paced APs and CTs with high signal-to-noise ratio and low phototoxicity. Quinidine, flecainide, E-4031, digoxin and cisapride prolonged APs, while verapamil and nifedipine shortened APs. Early after depolarizations (EADs) were elicited by quinidine, flecainide and cisapride. All but four compounds (amiodarone, chromanol, nifedipine, verapamil) prolonged AP rise time. Nifedipine and verapamil decreased CT amplitude, while digoxin increased CT amplitude. Pentamidine prolonged APs after chronic exposure.

Discussion: The Optopatch platform provides a robust assay to measure APs and CTs in hiPSC-CMs. This addresses the CiPA mandate and will facilitate comparisons of cell-based assays to human clinical data.

Keywords: Cardiomyocytes; Cardiotoxicity; Channelrhodopsin; Comprehensive in vitro Proarrhythmia Assay; Human induced pluripotent stem cells; Methods; Optogenetics; Pacing; Torsades de Pointes; Voltage indicator.

Similar articles

See all similar articles

Cited by 45 PubMed Central articles

See all "Cited by" articles

MeSH terms

Substances

Feedback